MARK A GOLDSMITH, Director at Constellation Pharmaceuticals, holds 862.35K shares in Revolution Medicines (Ticker: RVMD), holds 89.86K shares in Constellation Pharmaceuticals (Ticker: CNST).

See the Hottest Stocks Based on Insider Trading >

MARK A GOLDSMITH
Constellation Pharmaceuticals (CNST)
Director

Ranked #50,842 out of 100,370 Corporate Insiders

Profitable Transactions

2 out of 4 Profitable Transactions

Average Return

-0.70%

Average return per transaction

Time Frame

1 Year

Compare to

No Benchmark

How are Insiders Ranked?

Insider Holdings

100.00%

RVMD

A breakdown of MARK A GOLDSMITH's holdings

See the Top Stocks by Insiders

Insider Roles

Revolution Medicines
(RVMD)

President & CEO, Director

Roles that MARK A GOLDSMITH holds in companies

See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:

Revolution Medicines
(RVMD)

Rating:Informative Sell

Date:Sep 21, 2021 - Sep 21, 2022

Return:+45.50%

The most profitable trade made by MARK A GOLDSMITH

See the Latest Stocks Traded by Insiders

MARK A GOLDSMITH's Trading History

CNST

Constellation Pharmaceuticals

Dec 28, 2020

―

Uninformative Sell

140.74K

$3.05M

RVMD

Revolution Medicines

Dec 20, 2024

President & CEO, Director

Uninformative Buy

15.11K

$35.29M

List of latest transactions for each holding click on a transaction to see MARK A GOLDSMITH's performance on stock

See All Insider Trading from Today

MARK A GOLDSMITH insider profile FAQ

What is the percentage of profitable transactions made by MARK A GOLDSMITH?

The percentage of profitable transactions made by MARK A GOLDSMITH is 50%.

What is the average return per transaction made by MARK A GOLDSMITH?

The average return per transaction made by MARK A GOLDSMITH is -0.70%.

What stocks does MARK A GOLDSMITH hold?

MARK A GOLDSMITH holds: CNST, RVMD stocks.

What was MARK A GOLDSMITH’s latest transaction?

MARK A GOLDSMITH latest transaction was an Uninformative Buy of $15.11K.

What was MARK A GOLDSMITH's most profitable transaction?

MARK A GOLDSMITH’s most profitable transaction was an Informative Sell of RVMD stock on September 21, 2021. The return on the trade was 45.50%.

What is MARK A GOLDSMITH's role in Constellation Pharmaceuticals?

MARK A GOLDSMITH's role in Constellation Pharmaceuticals is Director.

How can I follow the stock ratings of top corporate insiders?

Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

MARK A GOLDSMITH Insider Profile

MARK A GOLDSMITH Constellation Pharmaceuticals (CNST)Director